Harbour BioMed raises $85M on heels of cancer deals

Immuno-oncology company Harbour BioMed (Shanghai, China) raised $85 million in a series B round led by GIC. New investors China Life Private

Read the full 229 word article

How to gain access

Continue reading with a
two-week free trial.